Congress’s PATH Caucus outlines a federal–state roadmap to integrate psychedelic-assisted therapy into U.S. care with clinical safeguards, data tracking and provider standards.

New EEG findings highlighted by DoubleBlind suggest baseline brain rhythms can forecast how intense an ayahuasca experience may feel—useful context for DMV readers.

From frankincense to mandrake, Scripture names plants with mind-altering potential. Here’s what shows up in the text—and how DMV readers can think about it today.

Estrogen’s influence on serotonin and glutamate links women’s health to psychedelic care. Here’s what patients and DMV providers should understand now.

As 5‑MeO‑DMT draws buzz, scientists and conservationists warn against “toad milking.” Here’s what’s known, what’s not, and how DMV readers should approach it.

From ganzfeld hit rates to DMT brain-wave shifts, we examine reported evidence on psychedelic ‘telepathy’—and offer grounded guidance for DC, Maryland and Virginia readers.

A viral DMT-and-laser ritual claims to reveal the universe’s “source code.” We unpack what participants report, what neuroscientists say, and how DMV readers should think about it.

DoubleBlind Mag spotlights rising 'pill shaming' in psychedelic spaces. Here’s what it means for people on SSRIs, the early research, and how DMV readers can stay safe.

A close look at new research on psychedelics, authoritarian attitudes, and what an April executive action could mean—plus why DMV cannabis rules are a separate lane.

A small primate study reported by DoubleBlind Mag hints ayahuasca may blunt stress-related brain changes linked to isolation—what it does and doesn’t mean for the DMV.

An Emory-led consortium is recruiting 800 adults in the US, Canada, and Australia for a first-of-its-kind study on difficulties that persist after psychedelic experiences.